Study to Assess Bioavailability of GLPG1690 Given as Oral Capsule or Tablet
Status:
Completed
Trial end date:
2017-06-14
Target enrollment:
Participant gender:
Summary
This study is a Phase I, randomized, open-label, cross-over study with three single-dose
treatments to compare the bioavailability of an oral tablet relative to an oral capsule of
GLPG1690 after single dose intake in healthy male subjects and to evaluate the effect of food
on the bioavailability of the oral tablet.